This Government Contract opportunity from Department Of Health And Human Services was posted on May 18, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SOLE SOURCE PLATINUM TAQ DNA POLYMERASE ASSAY KIT

Closed

051023TAQFederal

Submission Closed06/05/2023, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

Federal

Tau radiotracers for Baltimore Longitudinal Study of Aging

Solicitation # 75N98027Q00029

Solicitation 75N98027Q00029 is a Small Business Sources Sought Notice issued by the National Institutes of Health to identify qualified small business sources capable of providing FDA-approved second generation tau PET imaging radioligands. These radiotracers, specifically Lantheus product [18F]MK-6240, will be used in the Baltimore Longitudinal Study of Aging to measure brain tau neuropathology in participants using combined PET/CT scanners. The requirement consists of a base period and two option years, running from November 18, 2026, through November 17, 2029. The government seeks 70 doses for the base period and 70 doses for each of the two option periods. Interested contractors must submit their capability statements, business size status, and technical qualifications to the contracting officer by October 27, 2026. This notice is for market research purposes to determine the acquisition method and does not constitute a formal solicitation or commitment to award a contract.

National Institutes Of Health Nida

POSTED

DEADLINE

Custom Homing Peptide Synthesis and AAV Capsid ModificationThis subcontract for the Department of Veterans Affairs, specifically supporting the Harry S Truman Memorial Veterans Hospital, involves the synthesis of targeting peptides and genetic engineering services. The scope of work includes designing homing peptides, modifying AAV capsid genomes for peptide display, and producing modified viral vector prototypes. These activities are to be conducted using molecular cloning tools and DNA/RNA synthesis platforms within BSL-2 facilities. The selected provider must hold BSL-2 certification to deliver the required modified AAV vector constructs and synthesized peptide sequences. Performance of the contract will take place in Columbia, Missouri, under NAICS code 325414. The solicitation was posted on October 21, 2026, with a response deadline of November 4, 2026.

POSTED

DEADLINE

Brand Name - Dectomax (Doramectin) 500mL Injectable Solution

Solicitation # 12639527Q0009

Solicitation 12639527Q0009 is a combined synopsis and request for quotation issued by the Department of Agriculture for the procurement of 2,400 bottles of Dectomax (Doramectin) 500mL Injectable Solution. This firm-fixed-price acquisition is a total small business set-aside under NAICS code 325414 and is intended to support the USDA Cattle Fever Tick Eradication Program in Texas. The required items must be new and the exact brand name specified from Zoetis Inc., as alternate or substitute products are deemed technically unacceptable. All deliverables must be shipped F.O.B. destination to Laredo, Texas, within 30 days of the contract award. Award will be made based on best value, specifically to the lowest priced, technically acceptable offer with an acceptable or neutral past performance rating. To be considered technically acceptable, offerors must provide sufficient documentation, such as manufacturer quotes or datasheets, to verify the product and ensure a clear, auditable paper trail of traceability back to the original equipment manufacturer. Additionally, contractors must furnish a Certificate of Conformance per FAR 52.246-15. Quotations must remain firm for 90 calendar days, and the deadline for submission is October 30, 2026.

POSTED

DEADLINE

Supplier of Pressure Sensitive Adhesive Tape (NSN 7510-01-358-8770)This subcontract involves the supply of Type I Code M pressure sensitive adhesive tape to prime contractors supporting Department of Defense DLA supply contracts. The material must strictly adhere to NSN 7510-01-358-8770 and RA001 technical specifications. The scope of work requires the delivery of eight rolls of mercury-free tape, each maintaining a minimum shelf life of 24 months. Compliance with federal standards is mandatory, including packaging per MIL-STD-2073-1E, marking per MIL-STD-129, and hazardous material labeling according to the Hazard Communication Standard. Deliveries are to be made FOB Origin to DLA Distribution San Joaquin in Tracy, California. The opportunity is categorized under NAICS code 325414.

CONSTRUCTION & EQUIPMENT T & IFO EQ

POSTED

DEADLINE

Solicitation # SPE2DP-26-R-0001

Solicitation SPE2DP-26-R-0001 is a sole source request from the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of Japanese Encephalitis Virus (JEV) Vaccine, purified and inactivated, in single-dose prefilled syringes. The resulting contract will be a firm-fixed price, indefinite delivery, indefinite quantity (IDIQ) agreement with an eighteen-month base term. The government has established a minimum quantity of 277,760 units and a maximum quantity of 394,240 units, with the guaranteed minimum dollar value obligated at the time of award. Deliveries are required FOB Destination to DLA Distribution Susquehanna within 120 days after the date of order. To be eligible, offerors must provide proof of FDA approval to manufacture or sell the vaccine or a manufacturer's letter of commitment ensuring supply availability and fixed pricing for the contract duration. The product must adhere to MPID Number 5 and Medical Marking Standard No. 1D, specifically requiring cold chain storage between 2-8 degrees Celsius and serialization in accordance with the Drug Supply Chain Security Act. Proposals must be submitted electronically via the DLA Internet Bid Board System (DIBBS) by November 6, 2026, and must include unit pricing, as failure to provide this may lead to proposal rejection. Award will be based on the most advantageous offer considering price, FDA approval, and agreement to all solicitation terms.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VAC to Finished Vaccine ConversionThis subcontract involves the conversion of Government-owned Vaccine Antigen Concentrate into final-use Foot and Mouth Disease vaccine doses for prime contractors supporting USDA APHIS projects. The scope of work includes formulating the concentrate into a usable vaccine, performing filling and packaging within cleanroom facilities, and conducting essential final potency and efficacy testing. The project is managed under the Department of Agriculture and will be performed in Ames, Iowa. To be eligible, the contractor must hold a USDA Veterinary Biological Product License. The solicitation was posted on October 1, 2026, with a response deadline of November 10, 2026, falling under NAICS code 325414.

POSTED

DEADLINE

FMD Vaccine Antigen Concentrate (VAC) ProductionThis subcontract for the Department of Agriculture involves the production of Foot and Mouth Disease Vaccine Antigen Concentrates for prime contractors on USDA APHIS projects. The scope of work includes the purification and concentration of VAC serials, which are produced by engineering Master Seed Viruses or utilizing field strains in accordance with 9 CFR Parts 113 and 114. To qualify, the provider must possess a USDA Veterinary Biological Product License and provide propagation cell line data approved by the Center for Veterinary Biologics. The final deliverables are purified and concentrated FMD VAC serials, with performance taking place in Ames, Iowa. The response deadline for this opportunity is November 10, 2026.

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.

POSTED

DEADLINE

Antithrombin III Procurement

Solicitation # CBP-CON-00260

The National Blood Authority is seeking tenders for the procurement of an Antithrombin III product under solicitation number CBP-CON-00260. While the agency currently maintains supply arrangements for Thrombotrol through the National Fractionation Agreement for Australia, this request for tender opens the process for the provision of these essential medical supplies. Interested parties must submit their responses by the deadline of November 20, 2026. All inquiries and submissions should be directed to the CBP Procurement Team via the provided contact email. Further detailed specifications and requirements are contained within the official request for tender documentation.

National Blood Authority

POSTED

DEADLINE

Proteomics and Protein Expression AnalysisThe Proteomics and Protein Expression Analysis subcontract supports National Institutes of Health projects focused on identifying biomarkers related to substance exposure and brain development. The selected provider will perform protein identification and quantification for prime contractors using a variety of high-sensitivity methods, including mass spectrometry, ELISA, Western blotting, and protein-protein interaction assays via LC-MS/MS. To ensure the integrity of the results, the performing laboratory must adhere to ISO/IEC 17025 quality standards. The primary deliverables for this engagement consist of detailed quantitative biomarker reports and comprehensive protein expression profiles. This effort falls under NAICS code 325414 and is managed through the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

3 months ago

DEADLINE

N/A

General Info

Agency

Department Of Health And Human Services → Program Support Ctr Supply Svc Ctr

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedMay 18

special-notice

Response DeadlineJun 5

Deadline has passed

Submission Closed

06/05/2023, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → Program Support Ctr Supply Svc Ctr

Contacts1 person available

OfficePERRY POINT, MD, 21902, USA

Organization / AgencyDepartment Of Health And Human Services → Program Support Ctr Supply Svc Ctr

Office AddressPERRY POINT, MD, 21902, USA

Contacts

LESLIE LUCAS

contact@example.gov

Full Description

This is a notice of intent, not a request for proposals. A solicitation document will not be issued and proposals will not be requested. HHS, SUPPLY SERVICE CENTER, PERRY POINT, MARYLAND, intends to award a Firm-Fixed Price Contract to Thermo Fisher Scientific, 300 Industry Drive, Pittsburgh, PA 15275 to provide Platinum Taq DNA Polymerase enzyme kits. The proposed contract action intended use is by public health/BioWatch laboratories located across the country. DoD DBPAO conducted research and evaluated available Taq DNA Polymerase enzyme kits from lnvitrogen and other sources. Since there are no validated assays in the analytical format used by BioWatch laboratories for the biological threat agents of concern, use of the CDC LRN and DoD DBPAO assays are the only means to meet mission requirements. The DoD DBPAO assays were optimized and validated with the use of ThermoFisher Life Technologies (formerly lnvitrogen's) Platinum Taq DNA Polymerase enzyme kits. Mission success and consistency dictate ThermoFisher Life Technologies (formerly lnvitrogen's) Platinum Taq DNA Polymerase enzyme kits be used. No alternative product was identified during DoD DBPAO market research as being potentially equivalent. In the future, if any alternatives are identified and found to be equivalent, the DoD DBPAO assay procedures will have to be optimized and validated with the alternative Taq DNA Polymerase prior to it being used in BioWatch's mission. By its depth and breadth, this would be a lengthy (years) and expensive (millions of dollars) undertaking. The proposed contract action is for The Department of Homeland Security. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-04. The associated North American Industry Classification System (NAICS) Code is 325414. Interested vendors may identify their interests and capabilities to the requirement no later than 03:00 pm EST, June 5, 2023 by email only to leslie.lucas@psc.hhs.gov (NO PHONE CALLS). The Government will consider all responses, but a determination not to compete this action is solely under the discretion of the Government. This action is under the authority of 41 United States Code (U.S.C.) 253(c) (3)(B) as set forth in Federal Acquisition Regulation (FAR) 6.302-1 (Only one responsible source and no other supplies or services will satisfy agency requirements).

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS